Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmpeak Energy Regulatory News (AMP)

Share Price Information for Ampeak Energy (AMP)

Share Price is delayed by 15 minutes
Get Live Data
2.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.20 (8.00%)
Market Cap: £18.84m
AMP Live PriceLast checked at - London Stock Exchange

Intraday Ampeak Energy Share Chart

Partner Update

25 Oct 2010 07:00

RNS Number : 9104U
Amphion Innovations PLC
25 October 2010
 



 

 

EU certification for colour X ray technology will see the end of liquid flight ban

Major milestone for Amphion Partner Company, Kromek

 

London and New York, 25 October 2010 - Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, today announces that its Partner Company, Kromek, which specialises in the development of disruptive technology solutions for a range of commercial markets including airport and border security, has received official European Union (EU) certification to provide colour x-ray liquid detection systems to all European airports.

 

By April 2011, liquid items bought in transit (i.e. duty free purchases) will be allowed on board, providing the appropriate security measures, such as screening, are in place at the airports concerned. The results of the European Civil Aviation Conference (ECAC) led trials establish that the technology is ready to allow the 2011 deadline to be met by the airports. By April 2013, the ban will be lifted completely, allowing the carriage of liquids on flights across Europe.

 

Kromek's Bottle Scanner has qualified as a Category B device that has achieved Type 1 and Type 2 100% capability and has been officially tested, verified and authorised by ECAC. As of now, all EU airports are free to buy and implement Kromek's Bottle Scanner product, opening the company to the multi million dollar airport security market. 

 

The move marks a breakthrough in airport security. As the threat from liquid threat has become greater, airport security officials are seeking appropriate technology to mitigate this threat. For the first time, airports can purchase tested, approved, and secure technology that will allow authorities to relax the ban on liquid on flights.

 

Dr. Arnab Basu, CEO of Kromek, said, "It's a significant milestone for Kromek as the approved listing is vindication that colour x-ray detection has been proven. The next generation of X-ray technology has arrived, with a market ready machine that can detect liquid threat.

 

"The threat from Liquid, Aerosol and Gel (LAG) based explosives became apparent in August 2006 following discovery of a plot to use such devices aboard multiple transatlantic flights. Although Kromek had not set out to produce such equipment we were quick to realise with our capabilities we had the versatility to produce a solution for this market need.

 

Kromek's verified and approved solution effectively guards against such a possibility. It is a major step forward in the fight against global terrorism where liquid is increasingly becoming a common tool for terrorist use."

 

Kromek's revolutionary technology signals a new era in colour x-ray detection, and a market-changing development in aviation security. The company is introducing to the sector a pioneering form of detection, which has been likened to the advent of colour TV, from black and white, in terms of significance and market potential.

 

Richard Morgan, CEO of Amphion and Chairman of Kromek, said, "This approval by the ECAC is a major milestone for Kromek. Kromek's proven technology meets a previously unmet need in airport security. Kromek's Bottle Scanner should make a major contribution to a more efficient security system within the European markets."

 

Dr. Basu concluded, "The next year and beyond is extremely exciting for us. Kromek will continue to see strong growth over the coming years as our innovative solutions to many previously intractable problems captures the imagination.  Our groundbreaking technology not only provides products to the airline security market but has the opportunity for development into a range of products for many highly lucrative markets such as medical and industrial fields."

 

For further information please contact

Amphion Innovations plcCharlie Morgan +1 (212) 210 6224

Cardew GroupTim Robertson/ James Milton+44 20 7930 0777

Charles Stanley (Nominated Adviser) Mark Taylor+44 20 7149 6000

 

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 10 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.

On the web: www.amphionplc.com

About Kromek

Kromek was spun out of Durham University's physics department and specialises in the development of disruptive technology solutions for a broad range of commercial markets. It is currently pioneering digital colour imaging for x-rays and advanced 3D imaging for the medical, security, industrial inspection and defence markets. The company has successfully pioneered a revolutionary 3D x-ray technology, which has huge commercial benefits for a range of sectors, especially the airline security industry, where it is uniquely placed to fulfil an increasing, necessary worldwide demand for liquid explosive detection at airports.

On the web: www.kromek.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFEAFWEFSSEIS
Date   Source Headline
24th Sep 20107:00 amRNSIP Licensing
22nd Sep 20108:00 amRNSGrant Win by Partner Company Firestar
10th Sep 20107:00 amRNSHalf Yearly Report
8th Sep 20107:00 amRNSIssue of Equity
2nd Aug 20102:54 pmRNSTotal Voting Rights
30th Jun 20107:00 amRNSIssue of Equity
29th Jun 20107:00 amRNSPartner Company Kromek acquires US Company
8th Jun 20107:00 amRNSAGM Statement
18th May 20107:00 amRNSDirector/PDMR Shareholding
30th Mar 20103:21 pmRNSDirector/PDMR Shareholding
16th Mar 20107:00 amRNSFinal Results
15th Mar 20107:00 amRNSPartner Company Kromek Completes Fundraising
8th Mar 20107:00 amRNSNotice of Results
2nd Feb 20107:00 amRNSTrading Update
6th Jan 20107:00 amRNSDirector/PDMR Shareholding
23rd Dec 20097:01 amRNSFunding & IP Licensing Updates
25th Nov 20097:00 amRNSAmphion Partnership with Kuwait University
30th Oct 20095:11 pmRNSTotal Voting Rights
16th Oct 20092:37 pmRNSDirector/PDMR Shareholding
6th Oct 20098:59 amRNSPartner Company Wellgen Release
21st Sep 20092:41 pmRNSDirector/PDMR Shareholding
20th Aug 20097:00 amRNSHalf Yearly Report
25th Jun 20097:00 amRNSIP License Agreements
4th Jun 20097:00 amRNSAGM Statement
14th May 20095:26 pmRNSAnnual Financial Report
13th May 20095:29 pmRNSIssue of Equity
5th May 20097:00 amRNSIP License Agreements
1st May 20097:00 amRNSDirectorate Change
30th Apr 20095:05 pmRNSTotal Voting Rights
7th Apr 20093:54 pmRNSDirector/PDMR Shareholding
26th Mar 20093:47 pmRNSDirector/PDMR Shareholding
16th Mar 20097:00 amRNSFinal Results
4th Mar 200910:51 amRNSNotice of Results
27th Feb 20094:46 pmRNSDirector Dealings
27th Feb 20091:20 pmRNSAmphion Partner AXCESS International Wins Contract
30th Jan 20097:00 amRNSFunding Update
19th Jan 20097:00 amRNSTrading Statement
31st Dec 20087:00 amRNSConvertible Promisory Note Offering
27th Nov 20087:00 amRNSPartner Company Announces IP License Agreement
31st Oct 20083:46 pmRNSTotal Voting Rights
28th Oct 20087:00 amRNSNew CEO for Partner Company
23rd Oct 20087:00 amRNSDirector/PDMR Shareholding
17th Oct 20087:00 amRNSPartner Company Announces IP Licence Agreement
17th Sep 20087:00 amRNSPartner Company - Product Launch
16th Sep 20087:14 amRNSDirector/PDMR Shareholding
18th Aug 20087:00 amRNSInterim Results
1st Aug 20089:00 amRNSNotice of Interim Results
17th Jun 20082:54 pmRNSDirector/PDMR Shareholding
12th Jun 20087:00 amRNSAGM Statement
10th Jun 20087:00 amRNSPartner Company Announces IP

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.